Morning Overview on MSN

Magic mushroom therapy just jumped closer to FDA approval

The U.S. Food and Drug Administration issued its first formal guidance on how to design and run clinical trials for ...

FDA accepts New Drug Application for Roche’s giredestrant in ESR1-mutated, ER-positive advanced breast cancer

Filing acceptance based on phase III data showing giredestrant plus everolimus reduced the risk of disease progression or ...
PharmiWeb

FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer

Filing acceptance based on Phase III data showing giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1-mutated populations, respectively, versus ...
Lawrence Journal-World

KU’s Physics and Astronomy department hosting ‘Pluto Day’ event, celebrating science of space and the dwarf planet’s KU connection

It would be understandable if you stopped thinking as much about Pluto after it was “demoted” from being considered one of the nine planets sharing the Earth’s solar system to being classified as a ...

Travere Therapeutics Q4 Earnings Call Highlights

Travere Therapeutics (NASDAQ:TVTX) highlighted record demand for FILSPARI in IgA nephropathy (IgAN), provided an update on the U.S. Food and Drug Administration’s review timeline for a potential focal ...